GWILX
Price
$8.63
Change
-$7.81 (-47.51%)
Updated
Feb 3 closing price
Net Assets
3.97M
RMFCX
Price
$60.14
Change
-$1.74 (-2.81%)
Updated
Feb 3 closing price
Net Assets
111.52B
Interact to see
Advertisement

GWILX vs RMFCX

Header iconGWILX vs RMFCX Comparison
Open Charts GWILX vs RMFCXBanner chart's image
Glenmede SMID Core Equity Advisor
Price$8.63
Change-$7.81 (-47.51%)
VolumeN/A
Net Assets3.97M
American Funds American Mutual R3
Price$60.14
Change-$1.74 (-2.81%)
VolumeN/A
Net Assets111.52B
GWILX vs RMFCX Comparison Chart in %
View a ticker or compare two or three
VS
GWILX vs. RMFCX commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GWILX is a Hold and RMFCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 112B vs. GWILX (3.97M). RMFCX pays higher dividends than GWILX: RMFCX (1.24) vs GWILX (0.58). GWILX was incepted earlier than RMFCX: GWILX (10 years) vs RMFCX (24 years). GWILX (1.21) is less costly to investors than RMFCX (0.91). GWILX is a more actively managed with annual turnover of: 132.00 vs. RMFCX (30.00). GWILX has a lower initial minimum investment than RMFCX: GWILX (0) vs RMFCX (250). RMFCX annual gain was more profitable for investors over the last year : 7.45 vs. GWILX (-46.63). RMFCX return over 5 years is better than : 44.16 vs. GWILX (-45.57).
GWILXRMFCXGWILX / RMFCX
Total Expense Ratio0.850.9193%
Annual Report Gross Expense Ratio1.210.91133%
Fund Existence10 years24 years-
Gain YTD-0.6902.244-31%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets3.97M112B0%
Annual Yield % from dividends0.581.2447%
Returns for 1 year-46.637.45-626%
Returns for 3 years-38.7728.73-135%
Returns for 5 years-45.5744.16-103%
Returns for 10 years1.71105.792%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AXG3.010.18
+6.36%
Solowin Holdings Limited
TANH0.840.02
+2.72%
Tantech Holdings Ltd.
RCUS21.960.30
+1.39%
Arcus Biosciences
HOLX74.63-0.11
-0.15%
Hologic
CGTX1.12-0.02
-1.75%
Cognition Therapeutics